About

About Polpharma Biologics S.A. Polpharma Biologics is an international biotechnology company with integrated operations in the European Union, developing and manufacturing biosimilar medicines. Using patented solutions and state-of-the-art platform technologies, Polpharma Biologics develops biosimilar products to treat a range of conditions in major therapeutic areas. Programs at Polpharma Biologics start in cell line development and transition through technical and clinical development to commercial-scale production ready to be commercialized by our partners in all major pharmaceutical markets. The company’s expertise is in the development and manufacturing of medicines based on microbial & mammalian expression. Company is currently developing 10 molecules and in addition, have 2 biosimilars approved in multiple markets. These leading biosimilars are partnered with multiple companies for marketing rights to different territories.